Avid Bioservices (Avid Bioservices) Debt-to-Equity

: 1.06 (As of Oct. 2023)

View and export this data going back to 2014. Start your Free Trial

Avid Bioservices's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was $1.26 Mil. Avid Bioservices's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was $194.03 Mil. Avid Bioservices's Total Stockholders Equity for the quarter that ended in Oct. 2023 was $183.68 Mil. Avid Bioservices's debt to equity for the quarter that ended in Oct. 2023 was 1.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Avid Bioservices's Debt-to-Equity or its related term are showing as below:

CDMOP.PFD' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.98 Max: 3.68
Current: 1.06

During the past 13 years, the highest Debt-to-Equity Ratio of Avid Bioservices was 3.68. The lowest was 0.00. And the median was 0.98.

CDMOP.PFD's Debt-to-Equity is ranked worse than
88.81% of 1072 companies
in the Biotechnology industry
Industry Median: 0.15 vs CDMOP.PFD: 1.06

Avid Bioservices Debt-to-Equity Historical Data

The historical data trend for Avid Bioservices's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Debt-to-Equity

Get a 7-Day Free Trial

0.64

1.52

1.05

1.00

Avid Bioservices Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Debt-to-Equity	Get a 7-Day Free Trial															1.00	0.98	1.00	0.99	1.06

Competitive Comparison

For the Biotechnology subindustry, Avid Bioservices's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avid Bioservices Debt-to-Equity Distribution

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Debt-to-Equity falls into.

Avid Bioservices Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Avid Bioservices's Debt to Equity Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.358	+	187.875)	/	189.47
	=	1.00

Avid Bioservices's Debt to Equity Ratio for the quarter that ended in Oct. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.263	+	194.03)	/	183.675
	=	1.06

Avid Bioservices (NAS:CDMOP.PFD) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Avid Bioservices Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Avid Bioservices (Avid Bioservices) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMOP.PFD) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CDMO:USA TEHN:Germany

Address

14191 Myford Road, Tustin, CA, USA, 92780

Website

https://www.avidbio.com

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.